Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

NAFLD

A critical role for the NLRP3 inflammasome in NASH

This article has been updated

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 08 March 2017

    In the version of this article initially published online, the original article reference details were incorrect. This error has been corrected for the HTML and PDF versions of the article.

References

  1. Mridha, A. R. et al. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J. Hepatol. http://dx.doi.org/10.1016/j.jhep.2017.01.022 (2017)

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thomas, H. A critical role for the NLRP3 inflammasome in NASH. Nat Rev Gastroenterol Hepatol 14, 197 (2017). https://doi.org/10.1038/nrgastro.2017.21

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrgastro.2017.21

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing